Phillipp Torkler

Deggendorf, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Functional and genomic characterization of LCN2-deficient PC-3 cells reveals insights into prostate cancer progression.

Functional and genomic characterization of LCN2-deficient PC-3 cells reveals insights into prostate cancer progression.

Journal: Frontiers in molecular biosciences

Published: October 23, 2025

LoDEI: a robust and sensitive tool to detect transcriptome-wide differential A-to-I editing in RNA-seq data.

LoDEI: a robust and sensitive tool to detect transcriptome-wide differential A-to-I editing in RNA-seq data.

Journal: Nature communications

Published: April 24, 2024

Importance and implications of exosomes in nephrology and urology.

Importance and implications of exosomes in nephrology and urology.

Journal: Pflugers Archiv : European journal of physiology

Published: August 01, 2022

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.

Journal: Scientific reports

Published: December 06, 2021

Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.

Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.

Journal: World journal of urology

Published: October 28, 2021

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies.

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies.

Journal: Prostate cancer and prostatic diseases

Published: April 19, 2021

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy.

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy.

Journal: BMC urology

Published: May 01, 2020

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.

Journal: Prostate cancer and prostatic diseases

Published: February 08, 2020

A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.

A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.

Journal: European urology

Published: March 13, 2018

RNA-dependent chromatin association of transcription elongation factors and Pol II CTD kinases.

RNA-dependent chromatin association of transcription elongation factors and Pol II CTD kinases.

Journal: eLife

Published: February 01, 2017

Genome-wide Analysis of RNA Polymerase II Termination at Protein-Coding Genes.

Genome-wide Analysis of RNA Polymerase II Termination at Protein-Coding Genes.

Journal: Molecular cell

Published: June 21, 2016

Transcriptome maps of mRNP biogenesis factors define pre-mRNA recognition.

Transcriptome maps of mRNP biogenesis factors define pre-mRNA recognition.

Journal: Molecular cell

Published: May 05, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026